COVID - 19 Vaccination Update - Day 482 - Prevention is better than cure

Spread the Message

Read Time:1 Minute, 40 Second

Posted On: 12 MAY 2022 8:27PM by PIB Delhi

India’s COVID-19 vaccination coverage has crossed 190.97 Crore (1,90,97,52,061) today. More than 12 lakh (12,15,131) Vaccine Doses have been administered till 7 pm today. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs	1^st Dose	10406035
	2^nd Dose	10027674
	Precaution Dose	4991856
FLWs	1^st Dose	18417400
	2^nd Dose	17562012
	Precaution Dose	8088985
Age Group 12-14 years	1^st Dose	31273090
	2^nd Dose	11354899
Age Group 15-18 years	1^st Dose	58879905
	2^nd Dose	43679020
Age Group 18-44 years	1^st Dose	556479258
	2^nd Dose	483743406
	Precaution Dose	348046
Age Group 45-59 years	1^st Dose	203114924
	2^nd Dose	189393059
	Precaution Dose	917130
Over 60 years	1^st Dose	126997913
	2^nd Dose	118040662
	Precaution Dose	16036787
Cumulative 1^st dose administered		1005568525
Cumulative 2^nd dose administered		873800732
Precaution Dose		30382804
Total		1909752061

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 12^th April, 2022 (482^nd Day)
HCWs	1^st Dose	34
	2^nd Dose	513
	Precaution Dose	11314
FLWs	1^st Dose	102
	2^nd Dose	1166
	Precaution Dose	28407
Age Group 12-14 years	1^st Dose	166145
	2^nd Dose	282653
Age Group 15-18 years	1^st Dose	28543
	2^nd Dose	90890
Age Group 18-44 years	1^st Dose	45511
	2^nd Dose	305879
	Precaution Dose	16355
Age Group 45-59 years	1^st Dose	11891
	2^nd Dose	72532
	Precaution Dose	25050
Over 60 years	1^st Dose	5813
	2^nd Dose	49882
	Precaution Dose	72451
Cumulative 1^st dose administered		258039
Cumulative 2^nd dose administered		803515
Precaution Dose		153577
Total		1215131

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.